| scholarly article | Q13442814 |
| P50 | author | Björn Olsen | Q6025968 |
| Anna Gillman | Q88828748 | ||
| Shaman Muradrasoli | Q114338214 | ||
| Caroline Bröjer | Q114338216 | ||
| Jonas Waldenström | Q37375907 | ||
| Michelle Wille | Q45325125 | ||
| Hanna Söderström | Q57953902 | ||
| Josef D Järhult | Q87615710 | ||
| P2093 | author name string | Annika Daggfeldt | |
| Marie Nykvist | |||
| P2860 | cites work | Antiviral oseltamivir is not removed or degraded in normal sewage water treatment: implications for development of resistance by influenza A virus | Q21144425 |
| Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls | Q24556678 | ||
| Evolution and ecology of influenza A viruses | Q24634698 | ||
| Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses | Q27638589 | ||
| The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor | Q27642166 | ||
| H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis | Q27673887 | ||
| Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance | Q28282405 | ||
| Detection of the antiviral drug oseltamivir in aquatic environments | Q28475674 | ||
| Environmental levels of the antiviral oseltamivir induce development of resistance mutation H274Y in influenza A/H1N1 virus in mallards | Q28477046 | ||
| I222 Neuraminidase mutations further reduce oseltamivir susceptibility of Indonesian Clade 2.1 highly pathogenic Avian Influenza A(H5N1) viruses | Q28533778 | ||
| Resistance mutation R292K is induced in influenza A(H6N2) virus by exposure of infected mallards to low levels of oseltamivir | Q28535274 | ||
| Molecular surveillance of antiviral drug resistance of influenza A/H3N2 virus in Singapore, 2009-2013 | Q28543158 | ||
| Intra- and inter-pandemic variations of antiviral, antibiotics and decongestants in wastewater treatment plants and receiving rivers | Q28543255 | ||
| Influenza virus in a natural host, the mallard: experimental infection data | Q30000979 | ||
| H7N9: preparing for the unexpected in influenza | Q30151187 | ||
| Oseltamivir-resistant influenza A (H1N1) virus strain with an H274Y mutation in neuraminidase persists without drug pressure in infected mallards | Q30205021 | ||
| Antivirals for influenza: where now for clinical practice and pandemic preparedness? | Q30210112 | ||
| Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance | Q30222909 | ||
| Oseltamivir (Tamiflu(®)) in the environment, resistance development in influenza A viruses of dabbling ducks and the risk of transmission of an oseltamivir-resistant virus to humans - a review | Q30224096 | ||
| Stockpiling antiviral drugs for the next influenza pandemic | Q30227621 | ||
| Characterization of H7N9 influenza A viruses isolated from humans. | Q30352001 | ||
| The genesis and source of the H7N9 influenza viruses causing human infections in China | Q30353032 | ||
| A conformational restriction in the influenza A virus neuraminidase binding site by R152 results in a combinational effect of I222T and H274Y on oseltamivir resistance. | Q30357193 | ||
| Continuing challenges in influenza. | Q30363190 | ||
| The environmental fate of the antiviral drug oseltamivir carboxylate in different waters. | Q30371155 | ||
| Meetings of the WHO working group on surveillance of influenza antiviral susceptibility – Geneva, November 2011 and June 2012 | Q95438587 | ||
| Oseltamivir carboxylate, the active metabolite of oseltamivir phosphate (Tamiflu), detected in sewage discharge and river water in Japan | Q30384168 | ||
| Perspectives on influenza evolution and the role of research | Q30390922 | ||
| Occurrence and fate of oseltamivir carboxylate (Tamiflu) and amantadine in sewage treatment plants. | Q30392424 | ||
| The emergence of pandemic influenza viruses | Q30398146 | ||
| Photofate of oseltamivir (Tamiflu) and oseltamivir carboxylate under natural and simulated solar irradiation: kinetics, identification of the transformation products, and environmental occurrence | Q30401896 | ||
| Impact of mutations at residue I223 of the neuraminidase protein on the resistance profile, replication level, and virulence of the 2009 pandemic influenza virus | Q30411116 | ||
| Pathobiology and virus shedding of low-pathogenic avian influenza virus (A/H1N1) infection in mallards exposed to oseltamivir. | Q30425771 | ||
| Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan | Q30432260 | ||
| The influenza virus resource at the National Center for Biotechnology Information | Q33303008 | ||
| The evolutionary genetics and emergence of avian influenza viruses in wild birds | Q33339404 | ||
| Global patterns of influenza a virus in wild birds | Q33995214 | ||
| Epistatic interactions between neuraminidase mutations facilitated the emergence of the oseltamivir-resistant H1N1 influenza viruses | Q34339407 | ||
| Evolution of oseltamivir resistance mutations in Influenza A(H1N1) and A(H3N2) viruses during selection in experimentally infected mice. | Q34597005 | ||
| Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors | Q34615286 | ||
| Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium | Q35640944 | ||
| Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. | Q36870919 | ||
| Evolution of influenza A virus H7 and N9 subtypes, Eastern Asia | Q37261996 | ||
| Surveillance of influenza A virus in migratory waterfowl in northern Europe | Q37302767 | ||
| The neuraminidase inhibitor oseltamivir is effective against A/Anhui/1/2013 (H7N9) influenza virus in a mouse model of acute respiratory distress syndrome | Q37696588 | ||
| Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y. | Q37713074 | ||
| The I222V neuraminidase mutation has a compensatory role in replication of an oseltamivir-resistant influenza virus A/H3N2 E119V mutant | Q39627833 | ||
| Effect of oseltamivir carboxylate consumption on emergence of drug-resistant H5N2 avian influenza virus in Mallard ducks | Q40004651 | ||
| Dissemination, divergence and establishment of H7N9 influenza viruses in China | Q41242397 | ||
| Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate | Q41720424 | ||
| Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan. | Q42199847 | ||
| Synchronous dynamics of observed and predicted values of anti-influenza drugs in environmental waters during a seasonal influenza outbreak. | Q42288589 | ||
| Maximizing the value of drug stockpiles for pandemic influenza | Q42789427 | ||
| Antiviral drugs in wastewater and surface waters: a new pharmaceutical class of environmental relevance? | Q43182004 | ||
| Type A influenza virus detection and quantitation by real-time RT-PCR. | Q45396221 | ||
| Effects of influenza A virus infection on migrating mallard ducks. | Q51671413 | ||
| Universal primer set for the full-length amplification of all influenza A viruses | Q57202943 | ||
| Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child | Q79364184 | ||
| The development and application of a system for simultaneously determining anti-infectives and nasal decongestants using on-line solid-phase extraction and liquid chromatography-tandem mass spectrometry | Q83767426 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oseltamivir | Q211509 |
| P304 | page(s) | 5196-5202 | |
| P577 | publication date | 2015-06-15 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Influenza A(H7N9) virus acquires resistance-related neuraminidase I222T substitution when infected mallards are exposed to low levels of oseltamivir in water | |
| P478 | volume | 59 |
| Q47548869 | Environmental resistance development to influenza antivirals: a case exemplifying the need for a multidisciplinary One Health approach including physicians. |
| Q38686514 | H7N9 avian influenza A virus in China: a short report on its circulation, drug resistant mutants and novel antiviral drugs |
| Q30382548 | H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial. |
| Q40367217 | Identification of transformation products of antiviral drugs formed during biological wastewater treatment and their occurrence in the urban water cycle |
| Q43363515 | Photodegradation and ecotoxicology of acyclovir in water under UV254 and UV254/H2O2 processes. |
| Q28066861 | Risk of resistant avian influenza A virus in wild waterfowl as a result of environmental release of oseltamivir |
| Q92540850 | The evolution and characterization of influenza A(H7N9) virus under the selective pressure of peramivir |
| Q37296019 | The significance of naturally occurring neuraminidase quasispecies of H5N1 avian influenza virus on resistance to oseltamivir: a point of concern |
Search more.